Sotio

About:

Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.

Website: http://www.sotio.com

Top Investors: PPF Group

Description:

Sotio is an international biotechnology company leading the efforts of PPF Group to build a diverse biotechnology portfolio through its own research & development, collaborations, in-licensing, investments, mergers, and acquisitions. The company is developing new medical therapies, focusing on the treatment of cancer and autoimmune diseases. The most advanced project is the SOTIO proprietary platform of active cellular immunotherapy (ACI) based on dendritic cells.